Skip to main content

Ocular Therapeutix, Inc

OCUL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001393434

In the last 90 days, Ocular Therapeutix, Inc insiders filed 0 open-market purchases and 5 sales; 262 institutions reported holding it in 13F filings for Q2 2026, worth $2.03B in total; no superinvestor holds it.

13F holders, Q3 2024

Institutional positions in Ocular Therapeutix, Inc as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
168
+18 vs. Q2 2024
Shares held
140.0M
+14.1M (+11.2%) vs. Q2 2024
Total value
$1.22B
+$358.7M (+41.7%) vs. Q2 2024
New holders
35
42 more added
Sold out
17
48 more reduced

1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q2 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting OCUL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2024: 168 institutions
Q1 2021: 154 institutionsQ2 2021: 149 institutionsQ3 2021: 141 institutionsQ4 2021: 140 institutionsQ1 2022: 132 institutionsQ2 2022: 123 institutionsQ3 2022: 130 institutionsQ4 2022: 116 institutionsQ1 2023: 127 institutionsQ2 2023: 135 institutionsQ3 2023: 114 institutionsQ4 2023: 119 institutionsQ1 2024: 147 institutionsQ2 2024: 151 institutionsQ3 2024: 168 institutionsQ4 2024: 180 institutionsQ1 2025: 197 institutionsQ2 2025: 187 institutionsQ3 2025: 216 institutionsQ4 2025: 249 institutionsQ1 2026: 271 institutionsQ2 2026: 262 institutions
Value heldQ3 2024: $1.22B
Q1 2021: $774.9MQ2 2021: $685.8MQ3 2021: $445.7MQ4 2021: $289.1MQ1 2022: $215.4MQ2 2022: $178.2MQ3 2022: $177.6MQ4 2022: $111.3MQ1 2023: $213.8MQ2 2023: $224.2MQ3 2023: $127.0MQ4 2023: $328.8MQ1 2024: $1.12BQ2 2024: $939.8MQ3 2024: $1.22BQ4 2024: $1.14BQ1 2025: $1.01BQ2 2025: $1.45BQ3 2025: $2.20BQ4 2025: $2.33BQ1 2026: $1.77BQ2 2026: $2.03B
Institutions holding OCUL and their total value by quarter
QuarterHoldersValue
Q2 2026262$2.03B
Q1 2026271$1.77B
Q4 2025249$2.33B
Q3 2025216$2.20B
Q2 2025187$1.45B
Q1 2025197$1.01B
Q4 2024180$1.14B
Q3 2024168$1.22B
Q2 2024151$939.8M
Q1 2024147$1.12B
Q4 2023119$328.8M
Q3 2023114$127.0M
Q2 2023135$224.2M
Q1 2023127$213.8M
Q4 2022116$111.3M
Q3 2022130$177.6M
Q2 2022123$178.2M
Q1 2022132$215.4M
Q4 2021140$289.1M
Q3 2021141$445.7M
Q2 2021149$685.8M
Q1 2021154$774.9M

Institutions, Q3 2024

Shares, value and share of portfolio for each institution holding Ocular Therapeutix, Inc; share changes are against Q2 2024.

Institutions holding OCUL in Q3 2024
InstitutionSharesValue% of portfolioChange in sharesAction
Gsa Capital Partners LLP126,681$1.10M0.08%+126,681New
Manufacturers Life Insurance Company, The130,202$1.13M0.00%+13,238+11.3%Added
Citigroup Inc136,022$1.18M0.00%+71,712+111.5%Added
Raymond James & Associates142,108$1.24M0.00%−21,300−13.0%Reduced
UBS Asset Management Americas Inc147,684$1.28M0.00%−38,376−20.6%Reduced
Legato Capital Management LLC149,515$1.30M0.16%00.0%Unchanged
Alliancebernstein L.P.162,820$1.42M0.00%00.0%Unchanged
Banco Santander, S.A.172,231$1.50M0.02%−205,137−54.4%Reduced
Nottingham Advisors, Inc.185,766$1.62M0.18%−7,500−3.9%Reduced
State of Wisconsin Investment Board192,157$1.67M0.00%−49,791−20.6%Reduced
Swiss National Bank197,900$1.72M0.00%00.0%Unchanged
Two Sigma Investments, LP207,421$1.80M0.00%−328,698−61.3%Reduced
Rhumbline Advisers207,919$1.81M0.00%−3,382−1.6%Reduced
UBS Oconnor LLC221,659$1.93M0.05%−17,000−7.1%Reduced
Erste Asset Management GmbH235,800$2.05M0.02%00.0%Unchanged
Patient Square Capital LP235,498$2.05M0.76%+235,498New
Aptus Capital Advisors, LLC262,810$2.29M0.03%00.0%Unchanged
Second Line Capital, LLC262,810$2.29M0.62%00.0%Unchanged
Panagora Asset Management Inc264,355$2.30M0.01%+264,355New
Voya Investment Management LLC273,633$2.38M0.00%+185,582+210.8%Added
Paradigm Capital Management Inc400,000$3.48M0.15%+100,000+33.3%Added
PFM Health Sciences, LP402,843$3.50M0.20%+402,843New
Bank of New York Mellon Corp424,435$3.69M0.00%−71,200−14.4%Reduced
FMR LLC434,369$3.78M0.00%+428,335+7,098.7%Added
Pale Fire Capital SE438,200$3.81M0.60%+438,200New
Essex Investment Management Co LLC443,677$3.86M0.67%+1,168+0.3%Added
Wells Fargo & Company456,426$3.97M0.00%+405,107+789.4%Added
Wellington Management Group LLP462,864$4.03M0.00%+148,310+47.1%Added
Polar Asset Management Partners Inc.492,900$4.29M0.10%+492,900New
Nuveen Asset Management, LLC502,572$4.37M0.00%+85,799+20.6%Added
Barclays PLC511,522$4.45M0.00%+138,441+37.1%Added
Goldman Sachs Group Inc576,238$5.01M0.00%−103,179−15.2%Reduced
Knoll Capital Management, LLC600,400$5.22M2.52%+400,000+199.6%Added
AXA S.A.638,847$5.56M0.02%+1820.0%Added
UBS Group AG684,776$5.96M0.00%−63,957−8.5%Reduced
Nantahala Capital Management, LLC700,000$6.09M0.51%−300,000−30.0%Reduced
Cetera Investment Advisers719,498$6.26M0.01%−19,546−2.6%Reduced
Invesco Ltd.755,473$6.57M0.00%+709,573+1,545.9%Added
Bank of America Corp778,471$6.77M0.00%−257,700−24.9%Reduced
Deutsche Bank AG833,574$7.25M0.00%+26,264+3.3%Added
Rosalind Advisors, Inc.885,000$7.70M5.11%+135,000+18.0%Added
Price T Rowe Associates Inc977,396$8.50M0.00%−133,058−12.0%Reduced
Woodline Partners LP1,000,000$8.70M0.07%+1,000,000New
Artisan Partners Limited Partnership1,056,092$9.19M0.01%+1,056,092New
Charles Schwab Investment Management Inc1,110,460$9.66M0.00%+660,080+146.6%Added
Acuta Capital Partners, LLC1,190,071$10.4M8.39%−1,581,059−57.1%Reduced
Northern Trust Corp1,246,697$10.8M0.00%+167,420+15.5%Added
Franklin Resources Inc1,170,256$12.2M0.00%+930.0%Added
Morgan Stanley1,584,175$13.8M0.00%+421,694+36.3%Added
Point72 Asset Management, L.P.2,040,620$17.8M0.06%−666,043−24.6%Reduced
Braidwell LP2,239,770$19.5M0.55%+596,000+36.3%Added
Octagon Capital Advisors LP2,425,000$21.1M3.38%00.0%Unchanged
Deltec Asset Management LLC2,600,073$22.6M4.46%+9,808+0.4%Added
Assenagon Asset Management S.A.2,825,756$24.6M0.05%+2,825,756New
Geode Capital Management, LLC3,271,207$28.5M0.00%−180,880−5.2%Reduced
Perceptive Advisors LLC3,324,468$28.9M0.62%00.0%Unchanged
State Street Corp3,476,292$30.2M0.00%−444,371−11.3%Reduced
Logos Global Management LP3,500,000$30.4M3.41%−1,650,000−32.0%Reduced
Adage Capital Partners GP, L.L.C.3,750,000$32.6M0.06%+54,953+1.5%Added
Citadel Advisors LLC4,259,838$37.1M0.04%+205,976+5.1%Added
Opaleye Management Inc.5,025,000$43.7M7.29%−282,500−5.3%Reduced
TCG Crossover Management, LLC5,319,148$46.3M3.92%00.0%Unchanged
Avoro Capital Advisors LLC8,060,000$70.1M1.02%00.0%Unchanged
Vanguard Group Inc8,384,183$72.9M0.00%−227,918−2.6%Reduced
BlackRock, Inc.11,354,164$98.8M0.00%+11,354,164New
Deep Track Capital, LP12,721,460$110.7M3.53%00.0%Unchanged
VR Adviser, LLC12,762,462$111.0M5.82%00.0%Unchanged
Summer Road LLC14,398,193$125.3M98.66%−487,440−3.3%Reduced
Tri Locum Partners LP0$00.00%−514,642−100.0%Sold out
Artia Global Partners LP0$00.00%−500,000−100.0%Sold out
Jump Financial, LLC0$00.00%−123,442−100.0%Sold out
Alpine Global Management, LLC0$00.00%−41,165−100.0%Sold out
ADAR1 Capital Management, LLC0$00.00%−32,900−100.0%Sold out
Triumph Capital Management0$00.00%−30,761−100.0%Sold out
EntryPoint Capital, LLC0$00.00%−20,597−100.0%Sold out
HighTower Advisors, LLC0$00.00%−17,768−100.0%Sold out
Daymark Wealth Partners, LLC0$00.00%−15,000−100.0%Sold out
Palumbo Wealth Management LLC0$00.00%−12,667−100.0%Sold out
Dark Forest Capital Management LP0$00.00%−12,383−100.0%Sold out
Quantbot Technologies LP0$00.00%−10,834−100.0%Sold out
Algert Global LLC0$00.00%−10,114−100.0%Sold out
Inceptionr LLC0$00.00%−10,087−100.0%Sold out
Atlas Capital Advisors LLC0$00.00%−5,000−100.0%Sold out
Comerica Bank0$00.00%−234−100.0%Sold out
The PNC Financial Services Group, Inc.0$00.00%−106−100.0%Sold out
BlackRock Inc.––––Not filed